Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000697005 | SCV000825593 | pathogenic | Neurofibromatosis, type 1 | 2023-10-17 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ile679Phefs*9) in the NF1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NF1 are known to be pathogenic (PMID: 10712197, 23913538). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with NF1-related conditions. ClinVar contains an entry for this variant (Variation ID: 574937). For these reasons, this variant has been classified as Pathogenic. |
Ambry Genetics | RCV002422535 | SCV002718735 | pathogenic | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2020-12-14 | criteria provided, single submitter | clinical testing | The c.2034delG pathogenic mutation, located in coding exon 18 of the NF1 gene, results from a deletion of one nucleotide at nucleotide position 2034, causing a translational frameshift with a predicted alternate stop codon (p.I679Ffs*9). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |